Compare SVRA & OI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | OI |
|---|---|---|
| Founded | 2007 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 932.7M |
| IPO Year | 2009 | 1994 |
| Metric | SVRA | OI |
|---|---|---|
| Price | $4.90 | $5.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $11.06 | $6.50 |
| AVG Volume (30 Days) | 2.7M | ★ 4.1M |
| Earning Date | 11-24-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,426,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9,266.31 | $0.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.13 | $4.84 |
| 52 Week High | $7.01 | $16.91 |
| Indicator | SVRA | OI |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 37.29 |
| Support Level | $4.73 | $4.84 |
| Resistance Level | $5.47 | $5.62 |
| Average True Range (ATR) | 0.32 | 0.31 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 61.07 | 18.26 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
O-I Glass is the manufacturer of glass containers. The Company has two reportable segments and two operating segments based on its geographic locations: Americas and Europe. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food.